Sinn HP - Search Results

1

AGO Recommendations for the Surgical Therapy of the Axilla After Neoadjuvant Chemotherapy: 2021 Update.

Friedrich M, Kühn T, Janni W, Müller V, Banys-Pachulowski M, Kolberg-Liedtke C, Jackisch C, Krug D, Albert US, Bauerfeind I, Blohmer J, Budach W, Dall P, Fallenberg EM, Fasching PA, Fehm T, Gerber B, Gluz O, Hanf V, Harbeck N, Heil J, Huober J, Kreipe HH, Kümmel S, Loibl S, Lüftner D, Lux MP, Maass N, Möbus V, Mundhenke C, Nitz U, Park-Simon TW, Reimer T, Rhiem K, Rody A, Schmidt M, Schneeweiss A, Schütz F, Sinn HP, Solbach C, Solomayer EF, Stickeler E, Thomssen C, Untch M, Witzel I, Wöckel A, Thill M, Ditsch N. Friedrich M, et al. Among authors: sinn hp. Geburtshilfe Frauenheilkd. 2021 Oct;81(10):1112-1120. doi: 10.1055/a-1499-8431. Epub 2021 Oct 6. Geburtshilfe Frauenheilkd. 2021. PMID: 34629490 Free PMC article.

2

[Histologic regression of breast cancer after primary (neoadjuvant) chemotherapy].

Sinn HP, Schmid H, Junkermann H, Huober J, Leppien G, Kaufmann M, Bastert G, Otto HF. Sinn HP, et al. Geburtshilfe Frauenheilkd. 1994 Oct;54(10):552-8. doi: 10.1055/s-2007-1022338. Geburtshilfe Frauenheilkd. 1994. PMID: 8001751 German.

3

[Complete remission after salvage chemotherapy in metastatic breast carcinoma after failure of induction cycles of planned high dosage chemotherapy with stem cell support].

Solomayer EF, Diel IJ, Meyberg G, Sinn HP, Emig R, Wallwiener D, Bastert G. Solomayer EF, et al. Among authors: sinn hp. Zentralbl Gynakol. 1998;120(7):337-40. Zentralbl Gynakol. 1998. PMID: 9703656 German.

4

[Preoperative chemotherapy in primary operable breast cancer with a dose-dense combination of doxorubicin and docetaxel (ADoc) - Experience of the GEPARDO-GABG study group].

von Minckwitz G, Raab G, Schütte M, Hilfrich J, Blohmer JU, Gerber B, Costa SD, Merkle E, Eidtmann H, Lampe D, Jackisch C, du Bois A, Tulusan AH, Gademann G, Sinn HP, Caputo A, Graf E, Kaufmann M. von Minckwitz G, et al. Among authors: sinn hp. Zentralbl Gynakol. 2001 Sep;123(9):497-504. doi: 10.1055/s-2001-18222. Zentralbl Gynakol. 2001. PMID: 11709742 Review. German.

5

Stem cell dose and tumorbiologic parameters as prognostic markers for patients with metastatic breast cancer undergoing high-dose chemotherapy with autologous blood stem cell support.

Hensel M, Schneeweiss A, Sinn HP, Egerer G, Kornacker M, Solomayer E, Haas R, Bastert G, Ho AD. Hensel M, et al. Among authors: sinn hp. Stem Cells. 2002;20(1):32-40. doi: 10.1634/stemcells.20-1-32. Stem Cells. 2002. PMID: 11796920

6

P53 is the strongest predictor of survival in high-risk primary breast cancer patients undergoing high-dose chemotherapy with autologous blood stem cell support.

Hensel M, Schneeweiss A, Sinn HP, Egerer G, Solomayer E, Haas R, Bastert G, Ho AD. Hensel M, et al. Among authors: sinn hp. Int J Cancer. 2002 Jul 20;100(3):290-6. doi: 10.1002/ijc.10478. Int J Cancer. 2002. PMID: 12115543

7

Efficient engraftment of human primary breast cancer transplants in nonconditioned NOD/Scid mice.

Beckhove P, Schütz F, Diel IJ, Solomayer EF, Bastert G, Foerster J, Feuerer M, Bai L, Sinn HP, Umansky V, Schirrmacher V. Beckhove P, et al. Among authors: sinn hp. Int J Cancer. 2003 Jul 1;105(4):444-53. doi: 10.1002/ijc.11125. Int J Cancer. 2003. PMID: 12712433

8

The role of early expression of inducible nitric oxide synthase in human breast cancer.

Loibl S, Buck A, Strank C, von Minckwitz G, Roller M, Sinn HP, Schini-Kerth V, Solbach C, Strebhardt K, Kaufmann M. Loibl S, et al. Among authors: sinn hp. Eur J Cancer. 2005 Jan;41(2):265-71. doi: 10.1016/j.ejca.2004.07.010. Eur J Cancer. 2005. PMID: 15661552

9

Comparison of immunohistological parameters in primary breast cancers and corresponding locoregional recurrences.

Rom J, Aulmann S, Schneeweiss A, Sohn C, Sinn HP. Rom J, et al. Among authors: sinn hp. Pathol Res Pract. 2006;202(3):125-30. doi: 10.1016/j.prp.2005.12.002. Epub 2006 Feb 3. Pathol Res Pract. 2006. PMID: 16458445

10

Safety and pharmacokinetics of bivatuzumab mertansine in patients with CD44v6-positive metastatic breast cancer: final results of a phase I study.

Rupp U, Schoendorf-Holland E, Eichbaum M, Schuetz F, Lauschner I, Schmidt P, Staab A, Hanft G, Huober J, Sinn HP, Sohn C, Schneeweiss A. Rupp U, et al. Among authors: sinn hp. Anticancer Drugs. 2007 Apr;18(4):477-85. doi: 10.1097/CAD.0b013e32801403f4. Anticancer Drugs. 2007. PMID: 17351401 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

193 results

Search Page

Filters